THE CO-OPERATIVE CLINICAL CANCER THERAPY TRUST FUND
The Lymphoma Research Trust supports research into the treatment of lymphoma. It makes grants to medical researchers at the Lymphoma Trials Office who organise clinical trials to see which treatments are most effective.
Objects
THE STUDY AND RELIEF OF THOSE SUFFERING FROM LEUKAEMIA, HODGKINS DISEASE, TUMOURS OF THE LYMPH GLAND OR ANY SIMILAR OR RELATED MALIGNANT DISEASE, BY THE ESTABLISHMENT OF AN INSTITUTION TO SET UP AND MAINTAIN CO-OPERATION BETWEEN CLINICS AND OTHER INSTITUTIONS BY COLLATING RECORDING AND DISSEMINATING THE RESULTS OF CLINICAL THERAPY AND RESEARCH. (FOR DETAILS SEE CLAUSE 2 OF THE DECLARATION OF TRUST).
Financial health, per its FY2025 accounts
The accounts state that unrestricted reserves fell to £569,321, which is below the trustees' stated policy target of £808,027. The trustees note this is due to a period before the core grant is considered again, and confirm that resources are adequate to continue as a going concern.
What the accounts disclose
Policies the charity declares
- Conflicting interests
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Investing charity funds policy and procedures
- Investment
- Risk management
- Serious incident reporting policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
From the charity’s annual return (Part A, self-declared)
Self-declared on the annual return for the financial year ending 31/03/2025
- Grant-making is its main activity
Self-declared on the annual return for the financial year ending 31/03/2024
- Grant-making is its main activity
Self-declared on the annual return for the financial year ending 31/03/2023
- Grant-making is its main activity
Trustees
- Paul Smithchair
- Dr Christopher McNamara
- Dr Graham Collins
- Michael Ainley
- Penny Clarke
- Professor Jessica Okosun
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | £104k | £673k |
| 31/03/2024 | £121k | £111k |
| 31/03/2023 | £130k | £61k |
| 31/03/2022 | £143k | £574k |
| 31/03/2021 | £209k | £24k |
Common questions
Is THE CO-OPERATIVE CLINICAL CANCER THERAPY TRUST FUND financially healthy?
Per its FY2025 accounts: The accounts state that unrestricted reserves fell to £569,321, which is below the trustees' stated policy target of £808,027. The trustees note this is due to a period before the core grant is considered again, and confirm that resources are adequate to continue as a going concern. Its FY2025 accounts were independently examined.
Who funds THE CO-OPERATIVE CLINICAL CANCER THERAPY TRUST FUND?
Funders whose own accounts filings name THE CO-OPERATIVE CLINICAL CANCER THERAPY TRUST FUND as a grant recipient include THE KNOLL CHARITABLE TRUST.
Known funders
| Funder | Year | Amount | Purpose (as stated by the funder) |
|---|---|---|---|
| THE KNOLL CHARITABLE TRUST | FY2024 | £250 |
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE CAPRICORN FOUNDATION | 1 | £275k |
| THE PENNIES FOUNDATION | 1 | £44k |
| THE 29TH MAY 1961 CHARITY | 1 | £30k |
| BNA CHARITABLE INCORPORATED ORGANISATION | 1 | £25k |
| THE SYNCONA FOUNDATION | 1 | £20k |
| CECIL AND HILDA LEWIS CHARITABLE TRUST | 1 | £18k |
| THE ROAN CHARITABLE TRUST | 1 | £15k |
| WSH FOUNDATION | 1 | £8k |
Charities like this
- THE CANCER TREATMENT AND RESEARCH TRUST CIO
- CANCER CARE TRUST
- CURE LEUKAEMIA
- LYMPHOMA LEUKAEMIA MYELOMA FUND (WALES)
- THE THROMBOSIS RESEARCH TRUST
- TOPIC OF CANCER
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| THE CO-OPERATIVE CLINICAL CANCER THERAPY TRUST FUND | £104k | — | 0 | unclear | — | no doubt |
| THE CANCER TREATMENT AND RESEARCH TRUST CIO | £326k | — | 0 | above | — | no doubt |
| CANCER CARE TRUST | £48k | — | 0 | unclear | — | no doubt |
| CURE LEUKAEMIA | £3.7m | — | — | unclear | — | no doubt |
| LYMPHOMA LEUKAEMIA MYELOMA FUND (WALES) | £49k | — | 0 | unclear | — | no doubt |
| THE THROMBOSIS RESEARCH TRUST | £181k | — | 0 | above | — | no doubt |